uniQure (QURE) director exercises 11,685 options, sells shares under 10b5-1
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
uniQure N.V. director Balachandran Madhavan reported an exercise-and-sell transaction in Ordinary Shares. On June 17, 2026, he exercised stock options for 11,685 shares at strike prices of $19.39 and $31.71 per share.
The same total of 11,685 shares was then sold in open-market transactions at weighted average prices of $42.60, $43.66, and $47.08 per share. The filing states that the sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on March 10, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 11,685 shares ($526,485)
Net Sell
7 txns
Insider
Balachandran Madhavan
Role
null
Sold
11,685 shs ($526K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 5,295 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 6,390 | $0.00 | -- |
| Exercise | Ordinary Shares | 5,295 | $31.71 | $168K |
| Exercise | Ordinary Shares | 6,390 | $19.39 | $124K |
| Sale | Ordinary Shares | 5,295 | $47.08 | $249K |
| Sale | Ordinary Shares | 4,700 | $43.66 | $205K |
| Sale | Ordinary Shares | 1,690 | $42.60 | $72K |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 shares (Direct, null);
Ordinary Shares — 48,549 shares (Direct, null)
Footnotes (1)
- The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.00 to $47.36. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.12 to $43.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.93. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. The Stock Option vested in full on January 25, 2020. The Stock Option vested in full on January 26, 2019.
Key Figures
Shares sold: 11,685 shares
Sale prices: $42.60, $43.66, $47.08/share
Options exercised: 11,685 shares
+3 more
6 metrics
Shares sold
11,685 shares
Total Ordinary Shares sold in open-market transactions on June 17, 2026
Sale prices
$42.60, $43.66, $47.08/share
Weighted average sale prices for three sale tranches
Options exercised
11,685 shares
Total Ordinary Shares acquired via option exercises
Strike prices
$19.39 and $31.71/share
Exercise prices of two stock option grants
Net share change
-11,685 shares
Net buy/sell shares per transaction summary (net-sell)
Transaction date
June 17, 2026
Date of all reported transactions
Key Terms
Rule 10b5-1, weighted average price, Stock Option (Right to Buy), open-market sale, +1 more
5 terms
Rule 10b5-1 regulatory
"intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
FAQ
What did uniQure (QURE) director Balachandran Madhavan report in this Form 4?
He reported exercising options for 11,685 Ordinary Shares and selling the same number in open-market transactions. These trades combined a derivative exercise with immediate share sales at higher market prices.
What stock options did the uniQure (QURE) director exercise in this filing?
He exercised options for 6,390 shares at a $19.39 strike and 5,295 shares at a $31.71 strike. Both option grants had fully vested previously, with expirations in 2028 and 2029, respectively.